Location: North West England
Speciality: Cath Lab and Echo Physiologist
Location: South East Coast
Speciality: Cath Lab and Pacing Physiologist
Location: East Of England
A new drug has been proven to be adequate at treating stroke in irregular heartbeat patients, while also being easier to administer.
Research published in the New England Journal of Medicine found that rivaroxaban was just as effective as warfarin at cutting the risk of stroke among patients with this condition.
Usage of warfarin has to be monitored as its effects can be altered by other medications and diet, while those taking rivaroxaban do not require such close observation.
Manesh R Patel, of Duke University, said: "The results of this large global trial have convincingly shown rivaroxaban to be an alternative to warfarin in treating patients with atrial fibrillation and, importantly, with no increase in bleeding."
In other news, research published in the Journal of General Internal Medicine has found that heart patients who obtained new statin prescriptions through a mail-order system experienced better control of their cholesterol than those who collected their drugs from a pharmacy.
Written by Angela Newbury
Google has plans to detect the first signs of a heart attack, as well as diseases like cancer or even a stroke....
The world's first transplant of a non-beating heart has taken place in Australia. This could vastly increase...
Eating a diet rich in fish, oil and fruit and vegetables has long been highlighted as a way to keep a healthy...
A blood test can help identify the level of stroke risk in people who are genetically susceptible to developing...